Jessica Casaletto
0009-0007-4197-5612
1 paper found
Refreshing results…
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity acrossFGFR2Alterations and Resistance Mutations
Missing publications? Search for publications with a matching author name.